MedPath

A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

Phase 2
Terminated
Conditions
Polymyalgia Rheumatica
Interventions
Registration Number
NCT04972968
Lead Sponsor
AbbVie
Brief Summary

Polymyalgia rheumatica (PMR) is an inflammatory disease causing shoulder, hip, and neck pain and stiffness, in adults aged 50 years or older. This study evaluates how safe and effective ABBV-154 is in participants with glucocorticoid-dependent PMR. Adverse events and change in disease activity will be assessed.

ABBV-154 is an investigational drug being evaluated for the treatment of PMR. Participants will be randomized into 1 of 4 treatment groups or arms, each arm receiving a different treatment. There is a 1 in 4 chance that a participant will be assigned to placebo. Around 160 participants, of at least 50 years of age, with PMR will be enrolled in the study at approximately 95 sites worldwide.

The study is compromised of a 52 week double-blind, placebo-controlled period and a follow-up visit 70 days after the last dose of the study drug. All participants will receive a glucocorticoid taper along with the assigned dose of ABBV-154 or placebo, subcutaneously (SC) every other week (eow).

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
181
Inclusion Criteria
  • Clinical diagnosis of Polymyalgia Rheumatica (PMR) and fulfillment of the 2012 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) provisional classification criteria for PMR.
  • Must have had at least 2 episodes of unequivocal PMR flare.
  • Must be on a stable dose of prednisone.
  • Must be willing to follow the protocol-defined glucocorticoid tapering regimen.
Exclusion Criteria
  • Have been treated with a prior TNF antagonist.
  • Current use of immunomodulators other than prednisone and hydroxychloroquine.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboGlucocorticoidParticipants will receive placebo SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose BABBV-154Participants in this group will receive dose B of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose BGlucocorticoidParticipants in this group will receive dose B of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose AGlucocorticoidParticipants in this group will receive dose A of ABBV-154 subcutaneously (SC) every other week (eow) for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
PlaceboPlaceboParticipants will receive placebo SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose CABBV-154Participants in this group will receive dose C of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose AABBV-154Participants in this group will receive dose A of ABBV-154 subcutaneously (SC) every other week (eow) for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
ABBV-154 Dose CGlucocorticoidParticipants in this group will receive dose C of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.
Primary Outcome Measures
NameTimeMethod
Time to FlareFrom first dose of study drug to Week 52

Flare is defined as, presence of clinical signs and symptoms of PMR and requirement to increase the glucocorticoid dose per investigator.

Secondary Outcome Measures
NameTimeMethod
Percentage of Participants Achieving Flare-Free StateUp to Week 24

Percentage of participants achieving flare-free state.

Cumulative Glucocorticoid DoseWeek 24

Cumulative glucocorticoid dose.

Change From Baseline in Glucocorticoid DoseWeek 24

Change from Baseline in glucocorticoid dose.

Trial Locations

Locations (117)

Kistarcsai Flor Ferenc Korhaz /ID# 229676

🇭🇺

Kistarcsa, Hungary

Kuwana city medical center /ID# 231936

🇯🇵

Kuwana-shi, Mie, Japan

Hospital Universitario Marques de Valdecilla /ID# 229297

🇪🇸

Santander, Cantabria, Spain

Arthritis and Rheumatism Associates /ID# 232089

🇺🇸

Jonesboro, Arkansas, United States

Providence Medical Foundation /ID# 228681

🇺🇸

Fullerton, California, United States

Care Access Research, Huntington Beach /ID# 228677

🇺🇸

Huntington Beach, California, United States

Purushotham & Akther Kotha MD, Inc /ID# 245391

🇺🇸

La Mesa, California, United States

Arthritis & Osteo Medical Ctr /ID# 228680

🇺🇸

La Palma, California, United States

Hans Richard Barthel, M.D., Inc /ID# 231902

🇺🇸

Santa Barbara, California, United States

Medvin Clinical Research /ID# 228675

🇺🇸

Tujunga, California, United States

Inland Rheum & Osteo Med Grp /ID# 228679

🇺🇸

Upland, California, United States

Denver Arthritis Clinic /ID# 245736

🇺🇸

Denver, Colorado, United States

Delaware Arthritis /ID# 230110

🇺🇸

Lewes, Delaware, United States

Arthritis & Rheumatic Disease Specialties /ID# 245448

🇺🇸

Aventura, Florida, United States

Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 232238

🇺🇸

Boca Raton, Florida, United States

International Medical Research /ID# 228765

🇺🇸

Daytona Beach, Florida, United States

Omega Research Debary, LLC /ID# 245450

🇺🇸

DeBary, Florida, United States

Lakes Research, LLC /ID# 228757

🇺🇸

Miami, Florida, United States

HMD Research LLC /ID# 228767

🇺🇸

Orlando, Florida, United States

Springfield Clinic /ID# 228840

🇺🇸

Springfield, Illinois, United States

Four Rivers Clinical Research /ID# 228858

🇺🇸

Paducah, Kentucky, United States

Rheumatology Consultants - Clinical Research /ID# 232137

🇺🇸

Tupelo, Mississippi, United States

Dartmouth-Hitchcock Medical Center /ID# 229557

🇺🇸

Lebanon, New Hampshire, United States

Ocean Rheumatology, PA /ID# 232539

🇺🇸

Toms River, New Jersey, United States

Hospital for Special Surgery /ID# 228577

🇺🇸

New York, New York, United States

St. Lawrence Health System /ID# 229702

🇺🇸

Potsdam, New York, United States

University of Rochester Medical Center /ID# 232554

🇺🇸

Rochester, New York, United States

Paramount Medical Research Con /ID# 228839

🇺🇸

Middleburg Heights, Ohio, United States

Clinical Research Source, Inc. /ID# 231903

🇺🇸

Perrysburg, Ohio, United States

Altoona Ctr Clinical Res /ID# 232493

🇺🇸

Duncansville, Pennsylvania, United States

Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 228860

🇺🇸

Summerville, South Carolina, United States

West Tennessee Research Institute /ID# 228854

🇺🇸

Jackson, Tennessee, United States

Rheumatology Care Center PLLC /ID# 232306

🇺🇸

Bellaire, Texas, United States

DM Clinical Research - Tomball /ID# 245512

🇺🇸

Tomball, Texas, United States

Emeritus Research Sydney /ID# 229166

🇦🇺

Botany, New South Wales, Australia

Royal Prince Alfred Hospital /ID# 244888

🇦🇺

Camperdown, New South Wales, Australia

BJC Health /ID# 244839

🇦🇺

Paramatta, New South Wales, Australia

Tasman Health Care /ID# 230829

🇦🇺

Southport, Queensland, Australia

The Queen Elizabeth Hospital /ID# 229049

🇦🇺

Woodville South, South Australia, Australia

Emeritus Research /ID# 229270

🇦🇺

Camberwell, Victoria, Australia

Austin Health /ID# 229164

🇦🇺

Heidelberg, Victoria, Australia

Fiona Stanley Hospital /ID# 229050

🇦🇺

Murdoch, Western Australia, Australia

Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 229436

🇦🇹

Vienna, Wien, Austria

Rheumatology Research Associates /ID# 230363

🇨🇦

Edmonton, Alberta, Canada

The Waterside Clinic /ID# 230364

🇨🇦

Barrie, Ontario, Canada

CISSSBSL -Hopital regional de Rimouski /ID# 228394

🇨🇦

Rimouski, Quebec, Canada

Centre de Recherche Musculo-Squelettique /ID# 228392

🇨🇦

Trois-rivières, Quebec, Canada

CHU de Besancon - Jean Minjoz /ID# 244897

🇫🇷

Besancon, Doubs, France

Hopital de la Cavale Blanche /ID# 228348

🇫🇷

Brest, Finistere, France

CHU Montpellier - Hôpital Lapeyronie /ID# 228347

🇫🇷

Montpellier, Herault, France

Centre Hospitalier du Mans /ID# 229044

🇫🇷

Le Mans CEDEX 9, Sarthe, France

CHRU Tours - Hopital Trousseau /ID# 228349

🇫🇷

Chambray Les Tours, France

AP-HP - Hopital Cochin /ID# 231800

🇫🇷

Paris, France

Medius Klinik Kirchheim /ID# 228660

🇩🇪

Kirchheim unter Teck, Baden-Wuerttemberg, Germany

Immanuel Krankenhaus Berlin /ID# 228659

🇩🇪

Berlin-buch, Germany

Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 228661

🇩🇪

Berlin, Germany

MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH /ID# 228658

🇩🇪

Hamburg, Germany

Rheumazentrum Ratingen /ID# 245183

🇩🇪

Ratingen, Germany

Debreceni Egyetem Klinikai Kozpont /ID# 241674

🇭🇺

Debrecen, Hajdu-Bihar, Hungary

Obudai Egeszsegugyi Centrum Kft. Zalaegerszeg /ID# 229759

🇭🇺

Zalaegerszeg, Zala, Hungary

Clinexpert Kft /ID# 229677

🇭🇺

Budapest, Hungary

Obudai Egeszsegugyi Centrum Kft. /ID# 231121

🇭🇺

Budapest, Hungary

Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz /ID# 229758

🇭🇺

Gyula, Hungary

CMED Rehabilitacios es Diagnosztikai Kozpont /ID# 230065

🇭🇺

Szekesfehervar, Hungary

Csongrad-Csanad Megyei Dr. Bugyi Istvan Korhaz /ID# 229793

🇭🇺

Szentes, Hungary

ASL 3 Genovese - Ospedale la Colletta /ID# 229282

🇮🇹

Arenzano, Genova, Italy

A.O.U. Citta della Salute e della Scienza di Torino /ID# 229080

🇮🇹

Turin, Torino, Italy

Vital Medical Center Orvosi es Fogaszati Kozpont (Vital Medicina Kft.) /ID# 229674

🇭🇺

Veszprém, Hungary

Azienda Ospedaliero-Universitaria di Modena /ID# 228825

🇮🇹

Modena, Italy

Fondazione IRCCS Policlinico /ID# 245274

🇮🇹

Pavia, Italy

Azienda Ospedaliero-Universitaria Senese-Ospedale Santa Maria delle Scotte /ID# 245273

🇮🇹

Siena, Italy

Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 228815

🇮🇹

Udine, Italy

Daido Clinic /ID# 230204

🇯🇵

Nagoya-shi, Aichi, Japan

NHO Nagoya Medical Center /ID# 232420

🇯🇵

Nagoya-shi, Aichi, Japan

National Hospital Organization Shimoshizu National Hospital /ID# 230500

🇯🇵

Yotsukaido-shi, Chiba, Japan

Matsuyama Red Cross Hospital /ID# 230458

🇯🇵

Matsuyama-shi, Ehime, Japan

Sanuki Municipal Hospital /ID# 230202

🇯🇵

Sanuki-shi, Kagawa, Japan

Kyushu University Beppu Hospital /ID# 232250

🇯🇵

Beppu-shi, Oita, Japan

Japanese Red Cross Okayama Hospital /ID# 230857

🇯🇵

Okayama-shi, Okayama, Japan

Rinku Hashimoto Rheumatology Orthopaedics /ID# 246532

🇯🇵

Izumisano-shi, Osaka, Japan

Tokyo Medical And Dental University Hospital /ID# 232206

🇯🇵

Bunkyo-ku, Tokyo, Japan

Osaka Medical and Pharmaceutical University Hospital /ID# 246530

🇯🇵

Takatsuki-shi, Osaka, Japan

Toyama Prefectural Central Hospital /ID# 230616

🇯🇵

Toyama-shi, Toyama, Japan

Hanyang University Seoul Hospital /ID# 228719

🇰🇷

Seoul, Seoul Teugbyeolsi, Korea, Republic of

Kyungpook National University Hospital /ID# 228716

🇰🇷

Daegu, Korea, Republic of

ZiekenhuisGroep Twente /ID# 229071

🇳🇱

Almelo, Netherlands

Universitair Medisch Centrum Groningen /ID# 227727

🇳🇱

Groningen, Netherlands

Medisch Centrum Leeuwarden /ID# 245442

🇳🇱

Leeuwarden, Netherlands

Maastricht Universitair Medisch Centrum /ID# 227779

🇳🇱

Maastricht, Netherlands

Maasstad Ziekenhuis /ID# 228064

🇳🇱

Rotterdam, Netherlands

Optimal Clinical Trials Ltd /ID# 229048

🇳🇿

Grafotn, Auckland, New Zealand

Timaru Medical Specialists Ltd /ID# 229098

🇳🇿

Timaru, Canterbury, New Zealand

Aotearoa Clinical Trials /ID# 229099

🇳🇿

Papatoetoe, Auckland, New Zealand

Waikato Hospital /ID# 229047

🇳🇿

Hamilton, Waikato, New Zealand

Wellington Regional Hospital /ID# 229490

🇳🇿

Newtown, Wellington, New Zealand

CGM Research Trust /ID# 244893

🇳🇿

Christchurch Central, New Zealand

Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o /ID# 228357

🇵🇱

Wroclaw, Dolnoslaskie, Poland

Szpital Uniwersytecki nr 2 im. dr. Jana Biziela /ID# 228353

🇵🇱

Bydgoszcz, Kujawsko-pomorskie, Poland

Centrum Medyczne Reuma Park /ID# 244813

🇵🇱

Warszawa, Mazowieckie, Poland

Nova Reuma Domyslawska I Rusilowicz - Spolka Partnerska Lekarza Reumatologa I Fi /Id# 228466

🇵🇱

Bialystok, Podlaskie, Poland

AI Centrum Medyczne Sp. z o.o. sp.k. /ID# 228951

🇵🇱

Poznan, Wielkopolskie, Poland

Ortopedyczno-Rehabilitacyjny Szpital Kliniczny im. Wiktora Degi /ID# 228314

🇵🇱

Poznan, Wielkopolskie, Poland

Hospital Clínico Universitario de Santiago-CHUS /ID# 244868

🇪🇸

Santiago de Compostela, A Coruna, Spain

Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 244866

🇪🇸

Sabadell, Barcelona, Spain

Hospital Universitario Canarias /ID# 229451

🇪🇸

San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain

Hospital Clinic de Barcelona /ID# 229295

🇪🇸

Barcelona, Spain

Hospital General Universitario Gregorio Maranon /ID# 229302

🇪🇸

Madrid, Spain

Hospital Clinico Universitario San Carlos /ID# 229296

🇪🇸

Madrid, Spain

North West Anglia NHS Foundation Trust /ID# 230866

🇬🇧

Bretton, Cambridgeshire, United Kingdom

Leicester Royal Infirmary /ID# 231967

🇬🇧

Leicester, England, United Kingdom

The Royal Free London NHS Foundation Trust /ID# 231707

🇬🇧

London, London, City Of, United Kingdom

Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 231966

🇬🇧

Norwich, Norfolk, United Kingdom

Cardiff & Vale University Health Board /ID# 245297

🇬🇧

Cardiff, Wales, United Kingdom

UH Coventry & Warwickshire /ID# 228588

🇬🇧

Coventry, United Kingdom

NHS Lothian /ID# 245293

🇬🇧

Edinburgh, United Kingdom

Liverpool University Hospitals NHS Foundation Trust /ID# 245296

🇬🇧

Liverpool, United Kingdom

Portsmouth Hospitals University NHS Trust /ID# 245291

🇬🇧

Portsmouth, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath